Whitehawk Therapeutics (WHWK) Other Accumulated Expenses (2016 - 2026)
Whitehawk Therapeutics (WHWK) reported Other Accumulated Expenses of $106000.0 for Q1 2026, little changed quarter-over-quarter from $106000.0 in Q4 2025.
Whitehawk Therapeutics (WHWK) Other Accumulated Expenses (2016 - 2026) Analysis & Trends
Whitehawk Therapeutics (WHWK) has 10 years of Other Accumulated Expenses data on file, last reported at $106000.0 in Q1 2026.
- Other Accumulated Expenses for Q1 2026 came in at $106000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $106000.0 (changed N/A YoY), and the FY2025 annual result was $106000.0, down 83.69% from the prior year.
- Other Accumulated Expenses steadied at $106000.0 in Q1 2026 per WHWK's latest filing, from $106000.0 in the prior quarter.
- Over five years, Other Accumulated Expenses peaked at $668000.0 in Q1 2022 and troughed at $105000.0 in Q3 2025.
- A 4-year average of $291500.0 and a median of $110000.0 in 2025 frame the typical range for Other Accumulated Expenses.
- The sharpest annual moves came in 2022 and 2025: Other Accumulated Expenses soared 1774.67% in 2022, then tumbled 83.69% in 2025.
- A 4-year view of Other Accumulated Expenses shows it stood at $668000.0 in 2022, then fell by 2.69% to $650000.0 in 2024, then plunged by 83.69% to $106000.0 in 2025, then changed by 0.0% to $106000.0 in 2026.
- Business Quant data shows WHWK's Other Accumulated Expenses at $106000.0 in Q1 2026, $106000.0 in Q4 2025, and $105000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Whitehawk Therapeutics | 288.03 Mn | 164.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 106,000.00 |
| Dec 31, 2025 | 106,000.00 |
| Sep 30, 2025 | 105,000.00 |
| Jun 30, 2025 | 114,000.00 |
| Dec 31, 2024 | 650,000.00 |
| Mar 31, 2022 | 668,000.00 |
| Dec 31, 2021 | 496,000.00 |
| Sep 30, 2021 | 1.53 Mn |
| Jun 30, 2021 | 10,805.00 |
| Mar 31, 2021 | 35,633.00 |
| Dec 31, 2020 | 99,000.00 |
| Sep 30, 2020 | 21,579.00 |
| Jun 30, 2020 | 29,913.00 |
| Mar 31, 2020 | 17,984.00 |
| Dec 31, 2019 | 13,463.00 |
| Sep 30, 2019 | 29,106.00 |
| Jun 30, 2019 | 29,612.00 |
| Mar 31, 2019 | 50,498.00 |
| Dec 31, 2018 | 173,182.00 |
| Sep 30, 2018 | 89,114.00 |